Skip to content

HUB Organoids

services
technology
company
- about us
- careers
- events
- latest news
resources
license program
contact

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

eLife | Nov 2016

Contact Careers Privacy Policy

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

X

Have any questions?

contact us